Published OnlineFirst November 4, 2014. Clin Cancer Res Johann S. de Bono, Debashis Sarker, Joo Ern Ang, et al. patients with advanced solid tumors pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in First-in-human Phase I study of Pictilisib (GDC-0941), a potent Updated version 10.1158/1078-0432.CCR-14-0947 doi: Access the most recent version of this article at: Material Supplementary http://clincancerres.aacrjournals.org/content/suppl/2014/11/05/1078-0432.CCR-14-0947.DC1.html Access the most recent supplemental material at: Manuscript Author edited. Author manuscripts have been peer reviewed and accepted for publication but have not yet been E-mail alerts related to this article or journal. Sign up to receive free email-alerts Subscriptions Reprints and . pubs@aacr.org Department at To order reprints of this article or to subscribe to the journal, contact the AACR Publications Permissions . permissions@aacr.org Department at To request permission to re-use all or part of this article, contact the AACR Publications Research. on November 8, 2014. © 2014 American Association for Cancer clincancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on November 4, 2014; DOI: 10.1158/1078-0432.CCR-14-0947 Research. on November 8, 2014. © 2014 American Association for Cancer clincancerres.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Author Manuscript Published OnlineFirst on November 4, 2014; DOI: 10.1158/1078-0432.CCR-14-0947